Simmons Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.33M | Buy |
38,221
+20
| +0.1% | +$2.8K | 0.36% | 67 |
|
|
2025
Q4 | $4.69M | Buy |
38,201
+1,052
| +3% | +$128K | 0.31% | 76 |
|
|
2025
Q3 | $4.12M | Sell |
37,149
-1,414
| -4% | -$161K | 0.27% | 86 |
|
|
2025
Q2 | $4.28M | Buy |
38,563
+68
| +0.2% | +$7.24K | 0.3% | 81 |
|
|
2025
Q1 | $4.31M | Sell |
38,495
-1,563
| -4% | -$161K | 0.33% | 72 |
|
|
2024
Q4 | $3.7M | Buy |
40,058
+394
| +1% | +$35.5K | 0.27% | 96 |
|
|
2024
Q3 | $3.33M | Sell |
39,664
-3,366
| -8% | -$257K | 0.24% | 99 |
|
|
2024
Q2 | $2.95M | Buy |
43,030
+464
| +1% | +$31K | 0.22% | 101 |
|
|
2024
Q1 | $3.12M | Sell |
42,566
-4,418
| -9% | -$340K | 0.23% | 101 |
|
|
2023
Q4 | $3.81M | Sell |
46,984
-611
| -1% | -$47.5K | 0.31% | 83 |
|
|
2023
Q3 | $3.57M | Buy |
47,595
+668
| +1% | +$51.4K | 0.32% | 81 |
|
|
2023
Q2 | $3.62M | Buy |
46,927
+448
| +1% | +$35.7K | 0.3% | 84 |
|
|
2023
Q1 | $3.86M | Buy |
46,479
+365
| +0.8% | +$30.2K | 0.33% | 83 |
|
|
2022
Q4 | $3.96M | Sell |
46,114
-29
| -0.1% | -$2.3K | 0.34% | 78 |
|
|
2022
Q3 | $2.85M | Buy |
46,143
+1,070
| +2% | +$67.5K | 0.27% | 90 |
|
|
2022
Q2 | $2.79M | Buy |
45,073
+3,111
| +7% | +$193K | 0.24% | 96 |
|
|
2022
Q1 | $2.49M | Buy |
41,962
+166
| +0.4% | +$10.6K | 0.19% | 122 |
|
|
2021
Q4 | $3.04M | Sell |
41,796
-1,960
| -4% | -$135K | 0.21% | 106 |
|
|
2021
Q3 | $3.06M | Buy |
43,756
+342
| +0.8% | +$24K | 0.22% | 105 |
|
|
2021
Q2 | $2.99M | Sell |
43,414
-1,619
| -4% | -$108K | 0.22% | 107 |
|
|
2021
Q1 | $2.91M | Sell |
45,033
-930
| -2% | -$60K | 0.22% | 104 |
|
|
2020
Q4 | $2.68M | Buy |
45,963
+791
| +2% | +$47.7K | 0.21% | 110 |
|
|
2020
Q3 | $2.85M | Sell |
45,172
-11,517
| -20% | -$799K | 0.23% | 100 |
|
|
2020
Q2 | $4.36M | Buy |
56,689
+2,296
| +4% | +$176K | 0.36% | 68 |
|
|
2020
Q1 | $4.07M | Buy |
54,393
+38,068
| +233% | +$2.63M | 0.35% | 62 |
|
|
2019
Q4 | $1.06M | Sell |
16,325
-2,740
| -14% | -$178K | 0.1% | 177 |
|
|
2019
Q3 | $1.21M | Sell |
19,065
-786
| -4% | -$51.4K | 0.12% | 154 |
|
|
2019
Q2 | $1.34M | Sell |
19,851
-175
| -0.9% | -$11.5K | 0.13% | 147 |
|
|
2019
Q1 | $1.3M | Sell |
20,026
-220
| -1% | -$14.6K | 0.13% | 154 |
|
|
2018
Q4 | $1.27M | Buy |
20,246
+634
| +3% | +$44.3K | 0.14% | 138 |
|
|
2018
Q3 | $1.51M | Sell |
19,612
-2,469
| -11% | -$186K | 0.15% | 131 |
|
|
2018
Q2 | $1.56M | Sell |
22,081
-1,120
| -5% | -$79.1K | 0.14% | 130 |
|
|
2018
Q1 | $1.75M | Buy |
23,201
+241
| +1% | +$19.2K | 0.16% | 117 |
|
|
2017
Q4 | $1.65M | Sell |
22,960
-2,008
| -8% | -$152K | 0.17% | 112 |
|
|
2017
Q3 | $2.02M | Buy |
24,968
+1,984
| +9% | +$152K | 0.21% | 106 |
|
|
2017
Q2 | $1.63M | Sell |
22,984
-511
| -2% | -$34K | 0.18% | 108 |
|
|
2017
Q1 | $1.6M | Sell |
23,495
-772
| -3% | -$54.3K | 0.18% | 107 |
|
|
2016
Q4 | $1.74M | Buy |
24,267
+412
| +2% | +$30.6K | 0.2% | 108 |
|
|
2016
Q3 | $1.89M | Buy |
23,855
+650
| +3% | +$52.8K | 0.21% | 97 |
|
|
2016
Q2 | $1.94M | Buy |
23,205
+1,160
| +5% | +$103K | 0.22% | 97 |
|
|
2016
Q1 | $2.02M | Buy |
+22,045
| New | +$1.99M | 0.23% | 95 |
|
Other funds holding GILD
VCM
VPM
Simmons Bank's GILD Position: Q1 2026 in Review
Simmons Bank increased its Gilead Sciences (GILD) stake by 0.05% in Q1 2026, buying an estimated $2.8K and bringing the position to 38,221 shares worth $5.33M. The position accounts for 0.36% of the portfolio, ranked #67.
Simmons Bank first reported a position in GILD in Q1 2016 and has held it in 41 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Simmons Bank held 38,221 shares of Gilead Sciences worth $5.33M as of Q1 2026.
- Simmons Bank bought 20 Gilead Sciences shares in Q1 2026, an estimated $2.8K.
- Gilead Sciences made up 0.36% of Simmons Bank's portfolio in Q1 2026, its #67 holding.
- Simmons Bank first reported a position in Gilead Sciences in Q1 2016 and has held it in 41 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Simmons Bank's 13F filing for Q1 2026, filed 23 Apr 2026.